T-SARTAN-H PLUS Tablet Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of T-SARTAN-H PLUS Tablet.

Available Products of T-SARTAN-H PLUS Tablet

T-SARTAN-H PLUS Tablet 28's

Reg#: 055412

Description of T-SARTAN-H PLUS Tablet

Each tablet contains:Telmisartan……..80mg HCTZ……..………..12.5mg

Medicine Info

Pack Size: 28's

Company: Maple Pharmaceuticals (Pvt) Ltd

Price of T-SARTAN-H PLUS Tablet

Price: Rs. 2283.72

Related Keywords

  • T-SARTAN-H PLUS Tablet price in Pakistan
  • T-SARTAN-H PLUS Tablet tablet price
  • T-SARTAN-H PLUS Tablet Capsule price
  • Maple Pharmaceuticals (Pvt) Ltd T-SARTAN-H PLUS Tablet price
  • Buy T-SARTAN-H PLUS Tablet online
  • T-SARTAN-H PLUS Tablet containstelmisartan80mg uses
  • T-SARTAN-H PLUS Tablet syrup price
  • T-SARTAN-H PLUS Tablet pack 28's cost

T-SARTAN-H PLUS Tablet 2x7's

Reg#: 055412

Description of T-SARTAN-H PLUS Tablet

Each tablet contains:Telmisartan……..80mg HCTZ……..………..12.5mg

Medicine Info

Pack Size: 2x7's

Company: Maple Pharmaceuticals (Pvt) Ltd

Price of T-SARTAN-H PLUS Tablet

Price: Rs. 952.80

Related Keywords

  • T-SARTAN-H PLUS Tablet price in Pakistan
  • T-SARTAN-H PLUS Tablet tablet price
  • T-SARTAN-H PLUS Tablet Capsule price
  • Maple Pharmaceuticals (Pvt) Ltd T-SARTAN-H PLUS Tablet price
  • Buy T-SARTAN-H PLUS Tablet online
  • T-SARTAN-H PLUS Tablet containstelmisartan80mg uses
  • T-SARTAN-H PLUS Tablet syrup price
  • T-SARTAN-H PLUS Tablet pack 2x7's cost

Alternatives brands of T-SARTAN-H PLUS Tablet

Explore alternative brands for T-SARTAN-H PLUS Tablet below.

View Alternatives

Explore More Medicines

Mapnolol 40mg Tablet

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 168.2427

Gastimap Tablets

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 363.7687

ISDIN 10mgTablets

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 196.6329

METMIN 250mg Tablets

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 77.6527

METMIN 500mg Tablets

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 102.1761

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!